MicroRNAs as therapeutic targets and their potential applications in cancer therapy

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 8, 2012, Pages 747-759

  Cho, William C S ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Cancer; MicroRNA; Oncogene; Oncomir; Therapeutic target; Tumor suppressor gene

Indexed keywords

ANTAGOMIR; CPG OLIGODEOXYNUCLEOTIDE; DICER; DICER 1 PROTEIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HERMES ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MICRORNA; MICRORNA 100; MICRORNA 10B; MICRORNA 145; MICRORNA 21; MICRORNA 210; MICRORNA 211; MICRORNA 223; MICRORNA 9; PROTEIN KINASE B; SMAD3 PROTEIN; SMAD7 PROTEIN; SMALL UNTRANSLATED RNA; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRASTUZUMAB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNTRANSLATED RNA;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CELL CYCLE REGULATION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; DNA REPAIR; DRUG DELIVERY SYSTEM; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FEASIBILITY STUDY; GENE CLUSTER; GENE CONTROL; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HISTONE MODIFICATION; HODGKIN DISEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOLECULARLY TARGETED THERAPY; NEOPLASM; NONHUMAN; NUCLEOSOME; ONCOGENE; PHENOTYPE; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; NEOPLASMS; ONCOGENES;

EID: 84863906869     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.696102     Document Type: Review

References (79)

1. Cho WC. Conquering cancer through discovery research. IUBMB Life 2010;62:655-9
2. Almeida MI, Reis RM, Calin GA. microRNA history: Discovery, recent applications, and next frontiers. Mutat Res 2011;717:1-8
3. Cho WC. microRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010;42:1273-81
4. Cho WC. microRNAs in cancer - from research to therapy. Biochim Biophys Acta 2010;1805:209-17
5. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010;31:27-36
6. Chen T. The role of MicroRNA in chemical carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2010;28:89-124
7. Koturbash I, Zemp FJ, Pogribny I, et al. Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis. Mutat Res 2011;722:94-105
8. Bueno MJ, Malumbres M. microRNAs and the cell cycle. Biochim Biophys Acta 2011;1812:592-601
9. Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 2011;47:1127-37
10. Leucci E, Zriwil A, Gregersen LH, et al. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 2012;publish 6 Feb 2012; doi:10.1038/onc.2012.15
11. Zheng YS, Zhang H, Zhang XJ, et al. miR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene 2012;31:80-92
12. Lee DW, Futami M, Carroll M, et al. Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 2012;publish online 16 Jan 2012; doi:10.1038/onc.2011.579
13. Cai C, Ashktorab H, Pang X, et al. microRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5. PLoS ONE 2012;7:e29750
14. Lu Z, Li Y, Takwi A, et al. miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J 2011;30:57-67.
15. Jin Z, Selaru FM, Cheng Y, et al. microRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 2011;30:1577-85
16. Li X, Zhang Y, Zhang H, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.Mol Cancer Res 2011;9:824-33
17. Yang MH, Lin BR, Chang CH, et al. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/ FOXP1 signalling. Oncogene 2012;31:2401-11.
18. Jalava SE, Urbanucci A, Latonen L, et al. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene 2012;publish online 23 Jan 2012; doi:10.1038/onc.2011.624
19. Kim K, Chadalapaka G, Lee SO, et al. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 2012;31:1034-44
20. Turcatel G, Rubin N, El-Hashash A, et al. miR-99a and miR-99b modulate TGF-beta induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. PLoS One 2012;7:e31032
21. Smith AL, Iwanaga R, Drasin DJ, et al. The miR-106b-25 cluster targets Smad7,activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012;publish online 30 Jan 2012; doi:10.1038/onc.2012.11
22. Wang Y, Yu Y, Tsuyada A, et al. Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 2011;30:1470-80
23. Yan LX, Wu QN, Zhang Y, et al. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 2011;13:R2
24. van Der Fits L, van Kester MS, Qin Y, et al. microRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome. J Invest Dermatol 2011;131:762-8
25. Kwak HJ, Kim YJ, Chun KR, et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 2011;30:2433-42
26. Gabriely G, Yi M, Narayan RS, et al. Human glioma growth is controlled by microRNA-10b. Cancer Res 2011;71:3563-72
27. Kim K, Lee HC, Park JL, et al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 2011;6:740-51
28. Nishida N, Mimori K, Fabbri M, et al. microRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res 2011;17:2725-33
29. Zheng B, Liang L, Huang S, et al. microRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 2012;publish online 9 Dec 2011; doi:10.1038/onc.2011.581
30. Fang YX, Xue JL, ShenQ, et al. miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. Hepatology 2012;55:1852-62
31. Lee KM, Choi EJ, Kim IA. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol 2011;101:171-6
32. Saydam O, Senol O, Wurdinger T, et al. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res 2011;71:852-61
33. Cho WC, Chow AS, Au JS. miR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol 2011;8:125-31
34. Zhang J, Sun Q, Zhang Z, et al. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 2012;publish online 13 Feb 2012; doi:10.1038/onc.2012.28
35. Zhang JG, Guo JF, Liu DL, et al. microRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J Thorac Oncol 2011;6:671-8
36. Feng S, Cong S, Zhang X, et al. microRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 2011;39:6669-78
37. Paik JH, Jang JY, Jeon YK, et al. microRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res 2011;17:4761-71
38. Thomas M, Lange-Grunweller K, Weirauch U, et al. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 2012;31:918-28
39. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, et al. miR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 2012;33:732-9
40. Song Y, Xu Y, Wang Z, et al. microRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer 2012;publish online 23 Oct 2011; doi:10.1002/ijc.26485
41. Wu J, Wu G, Lv L, et al. microRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012;33:519-28
42. Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011;17:211-15
43. Lee YM, Lee JY, Ho CC, et al. microRNA 34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Breast Cancer Res 2011;13:R116
44. Wu G, Yu F, Xiao Z, et al. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 2011;105:146-53
45. Zhang W, Kong G, Zhang J, et al. microRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and Cyclin D1. PLoS One 2012;7:e31450
46. Almeida MI, Nicoloso MS, Zeng L, et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012;142:886-96.e9
47. Kim SJ, Shin JY, Lee KD, et al. microRNA let-7a suppresses breast cancer cell migration and invasion through down-regulation of C-C chemokine receptor type 7. Breast Cancer Res 2012;14:R14
48. Wu ZS, Wu Q, Wang CQ, et al. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer 2011;117:2842-52
49. Srivastava SK, Bhardwaj A, Singh S, et al. microRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 2011;32:1832-9
50. Viticchie G, Lena AM, Latina A, et al. miR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011;10:1121-31
51. Saini S, Majid S, Yamamura S, et al. Regulatory role of miR-203 in prostate cancer progression and metastasis. Clin Cancer Res 2011;17:5287-98
52. Wei JJ, Wu X, Peng Y, et al. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin Cancer Res 2011;17:1297-305
53. Qi J, Rice SJ, Salzberg AC, et al. miR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Cell Cycle 2012;11:177-86
54. Yamagishi M, Nakano K, Miyake A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NFW kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012;21:121-35
55. De Weer A, Van Der Meulen J, Rondou P, et al. EVI1-mediated down regulation of miR449a is essential for the survival of EVI1 positive leukaemic cells. Br J Haematol 2011;154:337-48
56. Tian X, Liu Z, Niu B, et al. E-cadherin/ beta-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011;2011:567305
57. Hirata H, Hinoda Y, Ueno K, et al. microRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 2012;33:41-8
58. Hirata H, Hinoda Y, Ueno K, et al. microRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. Carcinogenesis 2012;33:501-8
59. Chung TK, Lau TS, Cheung TH, et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 2012;130:1036-45
60. Zhang L, Sullivan PS, Goodman JC, et al. microRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res 2011;71:645-54
61. Kasinski AL, Slack FJ. Epigenetics and genetics. microRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011;11:849-64
62. Cho WC. Exploiting the therapeutic potential of microRNAs in human cancer. Expert Opin Ther Targets 2012;16:345-50
63. Gong C, Yao Y, Wang Y, et al. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 2011;286:19127-37
64. Kastl L, Brown I, Schofield AC. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res Treat 2012;131:445-54
65. Nalls D, Tang SN, Rodova M, et al. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One 2011;6:e24099
66. De Antonellis P, Medaglia C, Cusanelli E, et al. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15 +/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma. PLoS One 2011;6:e24584
67. Hikichi M, Kidokoro M, Haraguchi T, et al. microRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy. Mol Ther 2011;19:1107-15
68. Ibrahim AF, Weirauch U, Thomas M, et al. microRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011;71:5214-24
69. Kim SJ, Oh JS, Shin JY, et al. Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 2011;155:427-34
70. Yang YP, Chien Y, Chiou GY, et al. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 2012;33:1462-76
71. Zhang S, Shan C, Kong G, et al. microRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK).Oncogene 2012;publish online 21 Nov 2011; doi:10.1038/onc.2011.523
72. He XX, Chang Y, Meng FY, et al. microRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012;publish online 7 Nov 2011; doi:10.1038/onc.2011.500
73. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin 2010;60:376-92
74. Cho WC. Epigenomics. In: SCHWAB M, editor. Encyclopedia of cancer. 3rd edition. Springer; Heidelberg: 2012. In press
75. Cho WC. Targeting the signaling pathways in cancer therapy. Expert Opin Ther Targets 2012;16:1-3
76. Garofalo M, Croce CM. microRNAs: Master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol 2011;51:25-43
77. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-89
78. Cho WC. Grand challenges and opportunities in deciphering the role of non-coding RNAs in human diseases. Front Genet 2011;2:1
79. Cortez MA, Ivan C, Zhou P, et al. microRNAs in cancer: From bench to bedside. Adv Cancer Res 2010;108:113-57